Enibarcimab

Enibarcimab is a humanised murine monoclonal immunoglobulin G1 (IgG1) antibody, could be used for acute heart failure, COVID-19 infections and septic shock research[1].

Product Specifications

CAS Number

[2305638-98-4]

UNSPSC

12352203

Target

SARS-CoV

Type

Inhibitory Antibodies

Related Pathways

Anti-infection

Applications

COVID-19-anti-virus

Field of Research

Infection; Cardiovascular Disease

Assay Protocol

https://www.medchemexpress.com/enibarcimab.html

Purity

99.68

Solubility

10 mM in DMSO

Smiles

[Enibarcimab]

Molecular Weight

(145.82 kDa)

References & Citations

[1]James E, et al. The Immune System and Chronic Heart Failure: Is the Heart in Control? Journal of the American College of Cardiology. 2019. 53 (12) :1013-1020.